Artelo Biosciences, Inc. (ARTL)
NASDAQ: ARTL · Real-Time Price · USD
1.150
+0.050 (4.55%)
At close: Nov 20, 2024, 4:00 PM
1.140
-0.010 (-0.87%)
After-hours: Nov 20, 2024, 7:59 PM EST
Artelo Biosciences Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2021 | FY 2020 |
| Nov '24 Nov 20, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Aug '21 Aug 31, 2021 | Aug '20 Aug 31, 2020 |
| Market Capitalization | 4 | 4 | 8 | 22 | 22 | 4 | |
| Market Cap Growth | -14.18% | -45.90% | -62.41% | -1.60% | 416.89% | -35.18% | |
| Enterprise Value | -1 | -8 | -11 | 12 | 12 | 3 | |
| Last Close Price | 1.15 | 1.40 | 2.89 | 7.78 | 13.66 | 14.40 | |
| PB Ratio | 0.58 | 0.38 | 0.43 | 0.81 | 1.85 | 1.11 | |
| P/TBV Ratio | 0.84 | 0.46 | 0.48 | 0.87 | 2.23 | 2.35 | |
| Debt / Equity Ratio | 0.02 | 0.00 | 0.00 | 0.00 | 0.01 | - | |
| Quick Ratio | 6.97 | 8.08 | 17.57 | 23.48 | 19.13 | 4.28 | |
| Current Ratio | 7.15 | 8.51 | 18.36 | 23.96 | 19.61 | 4.66 | |
| Return on Equity (ROE) | -87.12% | -59.63% | -43.30% | - | -93.45% | -99.72% | |
| Return on Assets (ROA) | -52.66% | -37.09% | -26.42% | - | -54.68% | -53.94% | |
| Return on Capital (ROIC) | -56.54% | -39.73% | -27.52% | - | -58.09% | -62.74% | |
| Earnings Yield | -245.73% | -208.06% | -122.17% | -55.14% | -33.33% | -107.84% | |
| FCF Yield | -225.74% | -183.83% | -97.03% | -36.44% | -27.52% | -100.71% | |
| Buyback Yield / Dilution | -11.52% | -4.48% | -27.04% | -79.12% | -403.69% | -70.67% | |
| Total Shareholder Return | -11.52% | -4.48% | -27.04% | -79.12% | -403.69% | -70.67% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.